Editorial: Women in skin cancer vol II: 2022

por Ugurel, Selma, Patel, Sapna P.
Publicado 2023

Profile of ipilimumab and its role in the treatment of metastatic melanoma

por Patel, Sapna P, Woodman, Scott E
Publicado 2011

Profile of selumetinib and its potential in the treatment of melanoma

por Kim, Dae Won, Patel, Sapna P
Publicado 2014

Novel treatment paradigms for metastatic uveal melanoma

por Patel, Sapna P., Katz, Steven C.
Publicado 2022

Second Primary Malignancies in Patients With Melanoma Subtypes: Analysis of 120,299 Patients From the SEER Database (2000-2016)

por Loya, Asad, Gombos, Dan S., Patel, Sapna P.
Publicado 2022

Case Report: Neuromyelitis Optica After Treatment of Uveal Melanoma With Nivolumab and Ipilimumab

por Khimani, Karima, Patel, Sapna P., Whyte, Andrew, Al-Zubidi, Nagham
Publicado 2022

GNA11 Mutation in a Patient With Cutaneous Origin Melanoma: A Case Report

por Patel, Sapna P., Kim, Dae Won, Lacey, Carol L., Hwu, Patrick
Publicado 2016

The vaccine-site microenvironment: impacts of antigen, adjuvant, and same-site vaccination on antigen presentation and immune signaling

por Meneveau, Max O, Kumar, Pankaj, Lynch, Kevin T, Patel, Sapna P, Slingluff, Craig L
Publicado 2022

Adjuvant Ipilimumab in High-Risk Uveal Melanoma

por Fountain, Eric, Bassett, Roland L., Cain, Suzanne, Posada, Liberty, Gombos, Dan S., Hwu, Patrick, Bedikian, Agop, Patel, Sapna P.
Publicado 2019

Metastatic Risk Factors Associated with Class 1A Uveal Melanoma Patients

por Ballhausen, Alexej, Urias, Elizabeth, Gruschkus, Stephen K., Williams, Michelle, Glover, Maura S., Qin, Yong, Gombos, Dan S., Patel, Sapna P.
Publicado 2021

A phase II study of the insulin-like growth factor type I receptor inhibitor IMC-A12 in patients with metastatic uveal melanoma

por Mattei, Jane, Ballhausen, Alexej, Bassett, Roland, Shephard, Michael, Chattopadhyay, Chandrani, Hudgens, Courtney, Tetzlaff, Michael, Woodman, Scott, Sato, Takami, Patel, Sapna P.
Publicado 2020

Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor Growth

por Chattopadhyay, Chandrani, Bhattacharya, Rajat, Roszik, Jason, Khan, Fatima S., Wells, Gabrielle A., Villanueva, Hugo, Qin, Yong, Bhattacharya, Rishav, Patel, Sapna P., Grimm, Elizabeth A.
Publicado 2022

Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series

por Holbrook, Kourtney, Lutzky, Jose, Davies, Michael A., Davis, Jessica Michaud, Glitza, Isabella C., Amaria, Rodabe N., Diab, Adi, Patel, Sapna P., Amin, Asim, Tawbi, Hussein
Publicado 2019

Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma

por Lucci, Anthony, Addanki, Sridevi, Chiang, Yi-Ju, Meas, Salyna, Sarli, Vanessa N., Upshaw, Joshua R., Manchem, Mayank, Patel, Sapna P., Wargo, Jennifer A., Gershenwald, Jeffrey E., Ross, Merrick I.
Publicado 2023

The efficacy of anti‐programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma

por Ogata, Dai, Haydu, Lauren E., Glitza, Isabella C., Patel, Sapna P., Tawbi, Hussein A., McQuade, Jennifer L., Diab, Adi, Ekmekcioglu, Suhendan, Wong, Michael K., Davies, Michael A., Amaria, Rodabe N.
Publicado 2021

Intermittent MEK inhibition for the treatment of metastatic uveal melanoma

por Khan, Shaheer, Patel, Sapna P., Shoushtari, Alexander N., Ambrosini, Grazia, Cremers, Serge, Lee, Shing, Franks, Lauren, Singh-Kandah, Shahnaz, Hernandez, Susana, Sender, Naomi, Vuolo, Kristina, Nesson, Alexandra, Mundi, Prabhjot, Izar, Benjamin, Schwartz, Gary K., Carvajal, Richard D.
Publicado 2022

Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma

por Patel, Sapna P, Petroni, Gina R, Roszik, Jason, Olson, Walter C, Wages, Nolan A, Chianese-Bullock, Kimberly A, Smolkin, Mark, Varhegyi, Nikole, Gaughan, Elizabeth, Smith, Kelly T, Haden, Kathleen, Hall, Emily H, Gnjatic, Sacha, Hwu, Patrick, Slingluff, Craig L
Publicado 2021

Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy

por Qin, Yong, Bollin, Kathryn, de Macedo, Mariana Petaccia, Carapeto, Fernando, Kim, Kevin B, Roszik, Jason, Wani, Khalida M, Reuben, Alexandre, Reddy, Sujan T, Williams, Michelle D, Tetzlaff, Michael T, Wang, Wei-Lien, Gombos, Dan S, Esmaeli, Bita, Lazar, Alexander J, Hwu, Patrick, Patel, Sapna P
Publicado 2020

Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy

por Muñoz, Nina M., Williams, Malea, Dixon, Katherine, Dupuis, Crystal, McWatters, Amanda, Avritscher, Rony, Manrique, Soraya Zorro, McHugh, Kevin, Murthy, Ravi, Tam, Alda, Naing, Aung, Patel, Sapna P., Leach, David, Hartgerink, Jeffrey D., Young, Simon, Prakash, Punit, Hwu, Patrick, Sheth, Rahul A.
Publicado 2021

T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy

por Stephen, Bettzy, Hajjar, Joud, Sarda, Shrutii, Duose, Dzifa Yawa, Conroy, Jeffrey M, Morrison, Carl, Alshawa, Anas, Xu, Mingxuan, Zarifa, Abdulrazzak, Patel, Sapna P, Yuan, Ying, Kwiatkowski, Evan, Wang, Linghua, Rodon Ahnert, Jordi, Fu, Siqing, Meric-Bernstam, Funda, Lowman, Geoffrey M, Looney, Timothy, Naing, Aung
Publicado 2023